Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/31/2003CN1463701A Novel use of biphenyldicarboxylate as tumour multi-drug resistance inversion agent
12/31/2003CN1463700A Silymarin nano granular preparation and process for preparing the same
12/31/2003CN1463699A A composition for treating animal endometritis
12/31/2003CN1463698A Oral preparation compound containing Fudosteine
12/31/2003CN1463697A Fluctin slow release tablet
12/31/2003CN1132837C 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 Spiro furopyridine arylalkylamines, their preparation and intermediates and pharmaceutical compositions thereof and pharmaceutical use
12/31/2003CN1132836C 各种片螺素化合物和类似物的合成及中间体 And various synthetic intermediates lamellarin compounds and the like
12/31/2003CN1132833C Vinyl-pyrrolidone cynnematin with alkali subtituent
12/31/2003CN1132829C Crystalline N-acetyl neuraminic acid derivatives and process for their preparation
12/31/2003CN1132828C O-substd. hydroxy coumaranone derivs as antineoplastic and antitransfer agent
12/31/2003CN1132820C Crystal modified body of medicine
12/31/2003CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132818C 用作抗病毒剂的4－氧代－1,4－二氢－3－喹啉甲酰胺 As antiviral agents 4-oxo-1,4-dihydro-3-quinoline carboxamide
12/31/2003CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound
12/31/2003CN1132632C 缓释药物组合物 Release pharmaceutical composition
12/31/2003CN1132619C Medicine for treating myopia
12/31/2003CN1132618C Medicine for treating skin ulcer
12/31/2003CN1132612C Medicine for treating rheumatism and cold pain and its utilizing method
12/31/2003CN1132593C Mixture of white pepper and borneol and its application
12/31/2003CN1132587C Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
12/31/2003CN1132586C Immunomodulating compositions from bile
12/31/2003CN1132585C Water soluble medical chitose preparation and its preparation
12/31/2003CN1132584C Myopia treating eye drop
12/31/2003CN1132583C Medicine for treating foot ringwoorm
12/31/2003CN1132582C High-content famciclovir tablets
12/31/2003CN1132581C Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors
12/31/2003CN1132580C Carbostyril derivatives for curing ophthalmological diseases
12/31/2003CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions
12/31/2003CN1132578C Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CN1132557C 靶向局部治疗疾病的装置 Targeting apparatus topical treatment of diseases
12/31/2003CA2715558A1 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
12/31/2003CA2501963A1 Process for recovery of plant sterols from by-product of vegetable oil refining
12/31/2003CA2499709A1 Method for diagnosis of colorectal tumors
12/31/2003CA2493865A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
12/31/2003CA2492047A1 Short duration depot formulations
12/31/2003CA2491214A1 Acutumine and acutumine compounds, synthesis and use
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2491152A1 Oral pharmaceutical forms of liquid drugs having improved bioavailability
12/31/2003CA2490747A1 Method for generating monoclonal antibodies
12/31/2003CA2490725A1 Devices and methodologies useful in body aesthetics
12/31/2003CA2490704A1 Process for producing block copolymer/drug composite
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490636A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
12/31/2003CA2490526A1 Hetero-bicyclic compounds
12/31/2003CA2490452A1 .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan
12/31/2003CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490365A1 Quick dissolve compositions and tablets based thereon
12/31/2003CA2490354A1 Drug transport and delivery system
12/31/2003CA2490325A1 Transdermal aerosol compositions
12/31/2003CA2490232A1 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
12/31/2003CA2490124A1 Scaffolded maleimide clusters for multivalent peptide assembly
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2490108A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2490057A1 Metastable pharmaceutical compositions
12/31/2003CA2489991A1 Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl|ethoxy| acetic acid dihydrochloride (levocetririzine dihydrochloride)
12/31/2003CA2489987A1 Fluorosiloxane matrix controlled diffusion drug delivery system
12/31/2003CA2489984A1 Pharmaceutical compositions with improved dissolution
12/31/2003CA2489952A1 Soft solid antiperspirant with cooling and drying effect
12/31/2003CA2489947A1 Treatment of human multiple myeloma by curcumin
12/31/2003CA2489943A1 Methods for preventing and treating microbial infections by modulating transcription factors
12/31/2003CA2489911A1 Pasteurisation process for microbial cells and microbial oil
12/31/2003CA2489847A1 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
12/31/2003CA2489842A1 Aminoacetonitrile derivatives suitable for controlling parasites
12/31/2003CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003CA2489810A1 Use of thio-oxindole derivatives in treatment of skin disorders
12/31/2003CA2489806A1 Liposomes containing biologically active compounds
12/31/2003CA2489702A1 Novel anticholesterol compositions and method for using same
12/31/2003CA2489614A1 Oral preventive or therapeutic agent for skin damage containing diacylglyceryl ether
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2489545A1 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
12/31/2003CA2489528A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol
12/31/2003CA2489359A1 Propionic acid derivatives and their use as hppars activators
12/31/2003CA2489347A1 Transdermal drug delivery system
12/31/2003CA2489308A1 Use of taurine for the treatment of alopecia
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2488534A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/31/2003CA2488311A1 Combination treatment for depression and anxiety by nk1 and nk3 antagonists
12/31/2003CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487541A1 Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003CA2485537A1 Novel compounds, their use and preparation
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670493 Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds
12/30/2003US6670485 Vision disorders
12/30/2003US6670481 Oxiranecarboxylic acids for the treatment of diabetes
12/30/2003US6670478 Process for preparing torsemide intermediate
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
1 ... 5229 5230 5231 5232 5233 5234 5235 5236 5237 5238 5239 5240 5241 5242 5243 5244 5245 5246 5247 5248 5249 ... 7860